AngioDynamics Other Current Assets vs Current Deferred Revenue Analysis

ANGO Stock

USD 6.31 0.04 0.64%

AngioDynamics financial indicator trend analysis is way more than just evaluating AngioDynamics prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether AngioDynamics is a good investment. Please check the relationship between AngioDynamics Other Current Assets and its Current Deferred Revenue accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in AngioDynamics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price.

To learn how to invest in AngioDynamics Stock, please use our How to Invest in AngioDynamics guide.

Other Current Assets vs Current Deferred Revenue

Other Current Assets vs Current Deferred Revenue Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of AngioDynamics Other Current Assets account and Current Deferred Revenue. At this time, the significance of the direction appears to have significant contrarian relationship.

The correlation between AngioDynamics' Other Current Assets and Current Deferred Revenue is -0.22. Overlapping area represents the amount of variation of Other Current Assets that can explain the historical movement of Current Deferred Revenue in the same time period over historical financial statements of AngioDynamics, assuming nothing else is changed. The correlation between historical values of AngioDynamics' Other Current Assets and Current Deferred Revenue is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Other Current Assets of AngioDynamics are associated (or correlated) with its Current Deferred Revenue. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Current Deferred Revenue has no effect on the direction of Other Current Assets i.e., AngioDynamics' Other Current Assets and Current Deferred Revenue go up and down completely randomly.

Correlation Coefficient

-0.22

Relationship Direction	Negative
Relationship Strength	Insignificant

View All Relationships

Other Current Assets

Assets expected to be converted into cash, sold, or consumed either in one year or in the operating cycle, which are not included under standard current asset categories.

Current Deferred Revenue

Revenue that has been collected but not yet earned, typically from prepaid service contracts or subscriptions. This amount is considered a liability until the service is provided or the subscription period ends.

Most indicators from AngioDynamics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into AngioDynamics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in AngioDynamics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price.

To learn how to invest in AngioDynamics Stock, please use our How to Invest in AngioDynamics guide.At this time, AngioDynamics' Discontinued Operations is very stable compared to the past year. As of the 3rd of June 2024, Enterprise Value is likely to grow to about 352.9 M, while Selling General Administrative is likely to drop about 27.5 M.

	2021	2022	2023	2024 (projected)
Gross Profit	165.7M	174.2M	200.4M	129.6M
Total Revenue	316.2M	338.8M	389.6M	242.9M

Gross Profit Total Revenue

AngioDynamics fundamental ratios Correlations

	Common Stock Shares Outstanding	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Other Assets	Long Term Debt	Cash And Short Term Investments	Net Receivables	Common Stock Total Equity	Short Term Investments	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets
Common Stock Shares Outstanding		0.66	0.1	0.36	0.88	0.7	0.52	0.1	-0.15	-0.31	0.44	0.31	0.58	0.16	0.1	0.27	0.7	0.95	-0.34	0.26	0.78	-0.08	0.96	0.5	0.48	0.63
Total Assets	0.66		0.78	0.09	0.67	0.99	0.73	0.28	0.33	0.39	0.26	0.35	0.97	0.1	0.78	0.36	0.76	0.77	0.16	0.84	0.76	0.36	0.73	0.92	0.48	0.72
Short Long Term Debt Total	0.1	0.78		-0.17	0.27	0.68	0.63	0.18	0.66	0.75	0.03	0.13	0.81	0.01	0.99	0.15	0.56	0.24	0.39	0.95	0.43	0.54	0.19	0.89	0.3	0.4
Other Current Liab	0.36	0.09	-0.17		0.5	0.11	0.1	-0.66	-0.38	-0.59	0.8	0.31	-0.05	0.18	-0.13	0.33	0.32	0.37	-0.15	-0.14	0.12	0.01	0.4	0.04	0.08	0.44
Total Current Liabilities	0.88	0.67	0.27	0.5		0.66	0.65	-0.12	0.02	-0.26	0.61	0.26	0.58	0.17	0.28	0.25	0.87	0.9	-0.08	0.34	0.76	0.17	0.91	0.61	0.59	0.66
Total Stockholder Equity	0.7	0.99	0.68	0.11	0.66		0.66	0.35	0.21	0.32	0.25	0.41	0.94	0.15	0.69	0.42	0.72	0.81	0.14	0.75	0.75	0.31	0.77	0.84	0.46	0.77
Property Plant And Equipment Net	0.52	0.73	0.63	0.1	0.65	0.66		-0.2	0.71	0.13	0.44	-0.3	0.82	0.2	0.63	-0.3	0.88	0.63	0.31	0.71	0.82	0.54	0.61	0.8	0.78	0.2
Current Deferred Revenue	0.1	0.28	0.18	-0.66	-0.12	0.35	-0.2		-0.16	0.53	-0.64	0.43	0.25	-0.14	0.17	0.4	-0.19	0.08	-0.07	0.17	-0.02	-0.22	0.05	0.11	-0.08	0.28
Net Debt	-0.15	0.33	0.66	-0.38	0.02	0.21	0.71	-0.16		0.44	-0.01	-0.65	0.52	-0.01	0.64	-0.64	0.43	-0.02	0.48	0.65	0.4	0.59	-0.06	0.56	0.45	-0.34
Retained Earnings	-0.31	0.39	0.75	-0.59	-0.26	0.32	0.13	0.53	0.44		-0.57	0.19	0.43	-0.2	0.74	0.19	-0.02	-0.23	0.33	0.67	-0.08	0.26	-0.28	0.49	-0.1	0.13
Accounts Payable	0.44	0.26	0.03	0.8	0.61	0.25	0.44	-0.64	-0.01	-0.57		0.01	0.19	0.4	0.07	0.05	0.6	0.5	0.02	0.05	0.46	0.35	0.52	0.24	0.39	0.35
Cash	0.31	0.35	0.13	0.31	0.26	0.41	-0.3	0.43	-0.65	0.19	0.01		0.13	0.0	0.16	1.0	0.0	0.28	-0.24	0.1	-0.1	-0.24	0.28	0.17	-0.3	0.85
Non Current Assets Total	0.58	0.97	0.81	-0.05	0.58	0.94	0.82	0.25	0.52	0.43	0.19	0.13		0.08	0.8	0.13	0.76	0.7	0.22	0.89	0.79	0.4	0.65	0.94	0.55	0.53
Other Assets	0.16	0.1	0.01	0.18	0.17	0.15	0.2	-0.14	-0.01	-0.2	0.4	0.0	0.08		0.06	0.03	0.17	0.22	0.15	-0.07	0.15	0.19	0.22	-0.01	0.07	0.12
Long Term Debt	0.1	0.78	0.99	-0.13	0.28	0.69	0.63	0.17	0.64	0.74	0.07	0.16	0.8	0.06		0.18	0.55	0.26	0.44	0.94	0.43	0.57	0.2	0.89	0.27	0.43
Cash And Short Term Investments	0.27	0.36	0.15	0.33	0.25	0.42	-0.3	0.4	-0.64	0.19	0.05	1.0	0.13	0.03	0.18		0.0	0.27	-0.18	0.11	-0.11	-0.2	0.27	0.17	-0.3	0.85
Net Receivables	0.7	0.76	0.56	0.32	0.87	0.72	0.88	-0.19	0.43	-0.02	0.6	0.0	0.76	0.17	0.55	0.0		0.79	0.14	0.6	0.85	0.51	0.77	0.78	0.75	0.5
Common Stock Total Equity	0.95	0.77	0.24	0.37	0.9	0.81	0.63	0.08	-0.02	-0.23	0.5	0.28	0.7	0.22	0.26	0.27	0.79		-0.04	0.36	0.87	0.15	1.0	0.59	0.55	0.68
Short Term Investments	-0.34	0.16	0.39	-0.15	-0.08	0.14	0.31	-0.07	0.48	0.33	0.02	-0.24	0.22	0.15	0.44	-0.18	0.14	-0.04		0.25	0.12	0.71	-0.06	0.18	0.17	-0.07
Non Current Liabilities Total	0.26	0.84	0.95	-0.14	0.34	0.75	0.71	0.17	0.65	0.67	0.05	0.1	0.89	-0.07	0.94	0.11	0.6	0.36	0.25		0.55	0.42	0.31	0.96	0.35	0.41
Inventory	0.78	0.76	0.43	0.12	0.76	0.75	0.82	-0.02	0.4	-0.08	0.46	-0.1	0.79	0.15	0.43	-0.11	0.85	0.87	0.12	0.55		0.43	0.85	0.7	0.63	0.41
Other Current Assets	-0.08	0.36	0.54	0.01	0.17	0.31	0.54	-0.22	0.59	0.26	0.35	-0.24	0.4	0.19	0.57	-0.2	0.51	0.15	0.71	0.42	0.43		0.13	0.41	0.32	0.09
Other Stockholder Equity	0.96	0.73	0.19	0.4	0.91	0.77	0.61	0.05	-0.06	-0.28	0.52	0.28	0.65	0.22	0.2	0.27	0.77	1.0	-0.06	0.31	0.85	0.13		0.55	0.55	0.68
Total Liab	0.5	0.92	0.89	0.04	0.61	0.84	0.8	0.11	0.56	0.49	0.24	0.17	0.94	-0.01	0.89	0.17	0.78	0.59	0.18	0.96	0.7	0.41	0.55		0.48	0.55
Property Plant And Equipment Gross	0.48	0.48	0.3	0.08	0.59	0.46	0.78	-0.08	0.45	-0.1	0.39	-0.3	0.55	0.07	0.27	-0.3	0.75	0.55	0.17	0.35	0.63	0.32	0.55	0.48		0.12
Total Current Assets	0.63	0.72	0.4	0.44	0.66	0.77	0.2	0.28	-0.34	0.13	0.35	0.85	0.53	0.12	0.43	0.85	0.5	0.68	-0.07	0.41	0.41	0.09	0.68	0.55	0.12

Click cells to compare fundamentals

AngioDynamics Account Relationship Matchups

AngioDynamics fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Common Stock Shares Outstanding	38.0M	38.3M	39.0M	39.5M	45.4M	29.4M
Total Assets	595.5M	561.4M	552.8M	532.6M	612.5M	533.4M
Short Long Term Debt Total	40.8M	20M	33.8M	49.8M	57.3M	66.3M
Other Current Liab	2.1M	38.0M	21.5M	43.4M	49.9M	52.4M
Total Current Liabilities	51.5M	57.6M	74.3M	83.8M	96.4M	48.7M
Total Stockholder Equity	455.9M	439.5M	424.5M	378.3M	435.0M	404.2M
Property Plant And Equipment Net	28.3M	37.1M	45.0M	44.4M	51.0M	35.0M
Net Debt	(13.6M)	(28.2M)	5.0M	5.2M	6.0M	5.7M
Retained Earnings	(100.3M)	(131.9M)	(158.4M)	(210.9M)	(189.8M)	(180.3M)
Accounts Payable	19.1M	19.6M	28.0M	40.4M	46.5M	48.8M
Cash	54.4M	48.2M	28.8M	44.6M	51.3M	45.7M
Non Current Assets Total	442.6M	420.6M	409.4M	369.1M	424.5M	382.2M
Other Assets	5.2M	3.8M	11.0M	49.2M	56.6M	59.4M
Long Term Debt	40M	20M	25M	49.8M	57.3M	58.7M
Cash And Short Term Investments	54.4M	48.2M	28.8M	44.6M	51.3M	61.7M
Net Receivables	31.3M	35.4M	52.3M	52.8M	60.7M	38.3M
Common Stock Total Equity	374K	377K	380K	382K	439.3K	308.9K
Liabilities And Stockholders Equity	595.5M	561.4M	552.8M	532.6M	612.5M	533.4M
Non Current Liabilities Total	88.1M	64.4M	53.9M	70.5M	81.1M	80.5M
Inventory	59.9M	48.6M	51.4M	55.3M	63.6M	42.5M
Other Current Assets	2.2M	1.8M	2.2M	4.6M	4.2M	4.5M
Other Stockholder Equity	557.2M	567.8M	581.2M	593.5M	682.5M	424.4M
Total Liab	139.6M	122.0M	128.3M	154.3M	177.5M	129.1M
Property Plant And Equipment Gross	28.3M	37.1M	96.1M	44.4M	51.0M	37.5M
Total Current Assets	152.9M	140.9M	143.3M	163.5M	188.1M	151.2M
Accumulated Other Comprehensive Income	(1.3M)	3.2M	1.4M	(4.7M)	(5.4M)	(5.2M)
Short Term Debt	836K	2.4M	8.8M	14.8M	17.0M	8.5M
Intangible Assets	197.1M	169.0M	152.4M	111.1M	127.8M	113.3M
Common Stock	374K	377K	380K	382K	439.3K	309.7K
Property Plant Equipment	28.3M	37.1M	45.0M	44.4M	51.0M	34.9M
Non Currrent Assets Other	15.6M	13.2M	(5.1M)	54.3M	62.5M	65.6M
Other Liab	39.6M	37.1M	24.2M	17.4M	20.0M	32.6M
Good Will	201.5M	201.3M	201.1M	159.2M	183.1M	283.9M
Net Tangible Assets	57.2M	69.2M	71.1M	378.3M	435.0M	456.8M
Retained Earnings Total Equity	(100.3M)	(131.9M)	(158.4M)	(210.9M)	(189.8M)	(180.3M)
Long Term Debt Total	40M	20M	25M	49.8M	44.8M	69.2M
Capital Surpluse	561.9M	573.5M	586.9M	599.2M	689.1M	600.4M
Deferred Long Term Liab	24.1M	20.0M	16.0M	12.8M	14.7M	14.1M

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

When determining whether AngioDynamics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of AngioDynamics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Angiodynamics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Angiodynamics Stock:

How To Invest In AngioDynamics

Details

Is AngioDynamics Stock a good investment?

Details

What is AngioDynamics' Net Worth?

Details

Largest Health Care Equipment & Supplies Companies

View

Largest Health Care Equipment & Services Companies

View

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in AngioDynamics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price.

To learn how to invest in AngioDynamics Stock, please use our How to Invest in AngioDynamics guide.

Note that the AngioDynamics information on this page should be used as a complementary analysis to other AngioDynamics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stocks Directory module to find actively traded stocks across global markets.

Complementary Tools for AngioDynamics Stock analysis

When running AngioDynamics' price analysis, check to measure AngioDynamics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AngioDynamics is operating at the current time. Most of AngioDynamics' value examination focuses on studying past and present price action to predict the probability of AngioDynamics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AngioDynamics' price. Additionally, you may evaluate how the addition of AngioDynamics to your portfolios can decrease your overall portfolio volatility.

	Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences
	Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account
	Performance Analysis Check effects of mean-variance optimization against your current asset allocation
	Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
	Risk-Return Analysis View associations between returns expected from investment and the risk you assume
	Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon
	Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
	Transaction History View history of all your transactions and understand their impact on performance
	Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk
	Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges
	Money Managers Screen money managers from public funds and ETFs managed around the world

Is AngioDynamics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of AngioDynamics. If investors know AngioDynamics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about AngioDynamics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(4.80)

Revenue Per Share

8.105

Quarterly Revenue Growth

(0.07)

Return On Assets

(0.05)

Return On Equity

(0.62)

The market value of AngioDynamics is measured differently than its book value, which is the value of AngioDynamics that is recorded on the company's balance sheet. Investors also form their own opinion of AngioDynamics' value that differs from its market value or its book value, called intrinsic value, which is AngioDynamics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because AngioDynamics' market value can be influenced by many factors that don't directly affect AngioDynamics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between AngioDynamics' value and its price as these two are different measures arrived at by different means. Investors typically determine if AngioDynamics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, AngioDynamics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

AngioDynamics Other Current Assets vs Current Deferred Revenue Analysis

Other Current Assets vs Current Deferred Revenue

Other Current Assets vs Current Deferred Revenue Correlation Analysis

Correlation Coefficient

Other Current Assets

Current Deferred Revenue

AngioDynamics fundamental ratios Correlations

AngioDynamics Account Relationship Matchups

High Positive Relationship

High Negative Relationship

AngioDynamics fundamental ratios Accounts

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

Complementary Tools for AngioDynamics Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Cash And Short Term Investments	+ 1.0	Cash
Other Stockholder Equity	+ 1.0	Common Stock Total Equity
Total Stockholder Equity	+ 0.99	Total Assets
Long Term Debt	+ 0.99	Short Long Term Debt Total
Non Current Assets Total	+ 0.97	Total Assets
Other Stockholder Equity	+ 0.96	Common Stock Shares Outstanding

Current Deferred Revenue	- 0.66	Other Current Liab
Cash	- 0.65	Net Debt
Cash And Short Term Investments	- 0.64	Net Debt
Accounts Payable	- 0.64	Current Deferred Revenue
Retained Earnings	- 0.59	Other Current Liab
Accounts Payable	- 0.57	Retained Earnings